ResearchMoz

Cardiovascular Devices Market Research Reports & Industry Analysis

The global industry for cardiovascular devices has been demonstrating signs of rapid growth, with industry analysts anticipating robust growth and expansion in this segment over the next few years. It is estimated that the worldwide cardiovascular device industry will touch nearly USD 97 billion by the end of 2015. In 2010, this industry stood at an estimated value of USD 85 billion, according to market research reports.
The growing incidence of cardiovascular diseases and problems among people worldwide has propelled the cardiovascular devices industry over the past few years. According to the American Heart Association, globally over 80 million people suffer from heart health problems. Cardiovascular diseases account for over 17 million deaths worldwide annually.
Most cardiovascular problems are attributed to the change in dietary habits and an increasingly sedentary lifestyle among people globally. With the younger generation consuming higher amounts of sugar and fats, the incidence of heart-related problems is likely to grow. 
In fact, heart diseases have been ranked as the world’s leading factor for death and hence there is bound to be a higher demand for cardiovascular devices. This has prompted both governments and private institutions alike to invest heavily in research, development and health care and surgical facilities for better heart health among citizens.
The cardiovascular devices industry comprises of two key segments—diagnostic devices and interventional devices. These industry segments are likely to touch USD 16 billion and USD 74 billion over the next few years. Another key segment within this industry is that of support-related products.
Some of the key products within this category include: stents, drug eluting stents, catheters, pacemakers, defibrillators, echocardiography devices, ventricle support systems, guide wires, miniature cameras, and even artificial hearts.
ResearchMoz.us helps you keep abreast of the latest developments and trends in the cardiovascular devices industry. We sell market research reports that have been sourced from leading publishers from across the globe. Whether you are keen on gaining a global view of the latest in this sector or need region-specific market intelligence, you can rest assured that ResearchMoz.us has every market research report you need.
The world’s dependence on cardiovascular devices is poised to grow (with an expected market of USD 1.2 billion by 2017) and we keep you at the forefront of the next new trend. For more information and assistance, please speak with a Research Coordinator from ResearchMoz.

Cardiovascular Devices

Browse reports in Cardiovascular Devices

Displaying 1 to 30 (of 169 records)
MediPoint: Electrophysiology - Current and Future Players
Mar 2014   |   By - GlobalData
The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of...
$3500
MediPoint: Electrophysiology - US Analysis and Market Forecasts
Mar 2014   |   By - GlobalData
Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of...
$4450
MediPoint: Electrophysiology - EU Analysis and Market Forecasts
Mar 2014   |   By - GlobalData
Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of...
$4450
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts
Mar 2014   |   By - GlobalData
Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of...
$4450
MediPoint: Electrophysiology - South America Analysis and Market Forecasts
Mar 2014   |   By - GlobalData
Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of...
$4450
MediPoint: Electrophysiology - Global Analysis and Market Forecasts
Mar 2014   |   By - GlobalData
Still in its infancy, the electrophysiology (EP) device market has seen significant adoption and market growth as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device prices fall, and efficacy improves. This continued growth is also driven by technological advancements, including the emergence of...
$6495
Global and China Blood System Cardiovascular Agents Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Blood System Cardiovascular Agents basic information included Blood System Cardiovascular Agents definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Blood System Cardiovascular Agents industry policy...
$2200
Global and China Cardiovascular Devices Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Cardiovascular Devices basic information included Cardiovascular Devices definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Cardiovascular Devices industry policy and plan, Cardiovascular...
$2200
Global and China Peripheral Vascular Devices Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Peripheral Vascular Devices basic information included Peripheral Vascular Devices definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Peripheral Vascular Devices industry policy and plan,...
$2200
Global and China Cardiovascular Monitoring Systems Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Cardiovascular Monitoring Systems basic information included Cardiovascular Monitoring Systems definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Cardiovascular Monitoring Systems industry...
$2200
Global and China Cardiac Catheters and Guidewires Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Cardiac Catheters and Guidewires basic information included Cardiac Catheters and Guidewires definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Cardiac Catheters and Guidewires industry policy...
$2200
Cardiac Arrest Global Clinical Trials Review, H1, 2014
Jan 2014   |   By - GlobalData
GlobalData's clinical trial report, Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The...
$2500
Hypotension Global Clinical Trials Review, H1, 2014
Jan 2014   |   By - GlobalData
GlobalData's clinical trial report, Hypotension Global Clinical Trials Review, H1, 2014" provides data on the Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypotension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook...
$2500
Orthostatic Hypotension Global Clinical Trials Review, H1, 2014
Jan 2014   |   By - GlobalData
GlobalData's clinical trial report, Orthostatic Hypotension Global Clinical Trials Review, H1, 2014" provides data on the Orthostatic Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Orthostatic Hypotension. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
$2500
Reperfusion Injury Global Clinical Trials Review, H1, 2014
Jan 2014   |   By - GlobalData
GlobalData's clinical trial report, Reperfusion Injury Global Clinical Trials Review, H1, 2014" provides data on the Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Reperfusion Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the...
$2500
PharmaPoint: Microvascular Complications of Diabetes - US Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - France Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - Germany Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - Italy Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - Spain Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
PharmaPoint: Microvascular Complications of Diabetes - Japan Drug Forecast and Market Analysis to 2022
Dec 2013   |   By - GlobalData
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid...
$4995
MediPoint: Cardiac Rhythm Management - Global Analysis and Market Forecasts
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$6495
MediPoint: Cardiac Rhythm Management - EU Analysis and Market Forecasts
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$4450
MediPoint: Cardiac Rhythm Management - US Analysis and Market Forecasts
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$4450
MediPoint: Cardiac Rhythm Management - South America Analysis and Market Forecasts
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$4450
MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$4450
MediPoint: Cardiac Rhythm Management - Current and Future Players
Nov 2013   |   By - GlobalData
Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to...
$3500
Global and China Vascular Graft Industry 2013 Market Research Report
Nov 2013   |   By - QYResearch
The report firstly introduced Vascular Graft basic information included Vascular Graft definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Vascular Graft industry policy and plan, Vascular Graft product specification, manufacturing...
$2200
China Interventional Cardiovascular Device Industry Report, 2013 - 2015
Nov 2013   |   By - Research In China
With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients stimulated rapid growth in Chinese demand for interventional cardiac...
$2000
 
Displaying 1 to 30 (of 169 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData